Author Correction: A broader neutralizing antibody against all the current VOCs and VOIs targets unique epitope of SARS-CoV-2 RBD

Author Correction: A broader neutralizing antibody against all the current VOCs and VOIs targets unique epitope of SARS-CoV-2 RBD

Bibliographic Details
Main Authors:	Shuo Liu, Zijing Jia, Jianhui Nie, Ziteng Liang, Jingshu Xie, Lei Wang, Li Zhang, Xiangxi Wang, Youchun Wang, Weijin Huang
Format:	Article
Language:	English
Published:	Nature Publishing Group 2023-12-01
Series:	Cell Discovery
Online Access:	https://doi.org/10.1038/s41421-023-00619-y

Similar Items

A broader neutralizing antibody against all the current VOCs and VOIs targets unique epitope of SARS-CoV-2 RBD
by: Shuo Liu, et al.
Published: (2022-08-01)

Enhancing RBD exposure and S1 shedding by an extremely conserved SARS-CoV-2 NTD epitope
by: Qianhui Zhu, et al.
Published: (2024-08-01)

Development of a Triple-Color Pseudovirion-Based Assay to Detect Neutralizing Antibodies against Human Papillomavirus
by: Jianhui Nie, et al.
Published: (2016-04-01)

Antigenicity comparison of SARS‐CoV‐2 Omicron sublineages with other variants contained multiple mutations in RBD
by: Qianqian Li, et al.
Published: (2022-06-01)

Sera from breakthrough infections with SARS-CoV-2 BA.5 or BF.7 showed lower neutralization activity against XBB.1.5 and CH.1.1
by: Shuo Liu, et al.
Published: (2023-12-01)

Development of a SARS‐CoV‐2 neutralization assay based on a pseudotyped virus using a HIV system
by: Ziteng Liang, et al.
Published: (2024-04-01)

The antigenicity of SARS-CoV-2 Delta variants aggregated 10 high-frequency mutations in RBD has not changed sufficiently to replace the current vaccine strain
by: Jiajing Wu, et al.
Published: (2022-01-01)

Optimization and validation of a virus‐like particle pseudotyped virus neutralization assay for SARS‐CoV‐2
by: Shuo Liu, et al.
Published: (2024-06-01)

Neutralizing and Enhancing Epitopes of the SARS-CoV-2 Receptor-Binding Domain (RBD) Identified by Nanobodies
by: Kanasap Kaewchim, et al.
Published: (2023-05-01)

Identification of a highly conserved neutralizing epitope within the RBD region of diverse SARS-CoV-2 variants
by: Yanqun Wang, et al.
Published: (2024-01-01)

Inducing enhanced neutralizing antibodies against broad SARS-CoV-2 variants through glycan-shielding multiple non-neutralizing epitopes of RBD
by: Qingyun Zhang, et al.
Published: (2023-12-01)

Glycan Masking of Epitopes in the NTD and RBD of the Spike Protein Elicits Broadly Neutralizing Antibodies Against SARS-CoV-2 Variants
by: Wei-Shuo Lin, et al.
Published: (2021-12-01)

Reduced sensitivity of the SARS-CoV-2 Lambda variant to monoclonal antibodies and neutralizing antibodies induced by infection and vaccination
by: Meiyu Wang, et al.
Published: (2022-12-01)

Novel neutralizing SARS-CoV-2-specific mAbs offer detection of RBD linear epitopes
by: Seyed Mostafa Mostafavi Zadeh, et al.
Published: (2024-02-01)

Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern
by: Ashlesha Deshpande, et al.
Published: (2021-06-01)

HIV-1 pseudoviruses constructed in China regulatory laboratory
by: Jianhui Nie, et al.
Published: (2020-01-01)

Leukotoxin of Bibersteinia trehalosi Contains a Unique Neutralizing Epitope, and a Non-Neutralizing Epitope Shared with Mannheimia haemolytica Leukotoxin
by: Arumugam Murugananthan, et al.
Published: (2018-05-01)

Development of an automated, high-throughput SARS-CoV-2 neutralization assay based on a pseudotyped virus using a vesicular stomatitis virus (VSV) vector
by: Ziteng Liang, et al.
Published: (2023-12-01)

Comparison of two high-throughput assays for quantification of adenovirus type 5 neutralizing antibodies in a population of donors in China.
by: Qiang Liu, et al.
Published: (2012-01-01)

A novel bispecific antibody targeting two overlapping epitopes in RBD improves neutralizing potency and breadth against SARS-CoV-2
by: Hancong Sun, et al.
Published: (2024-12-01)

A novel high-throughput vaccinia virus neutralization assay and preexisting immunity in populations from different geographic regions in China.
by: Qiang Liu, et al.
Published: (2012-01-01)

Development of a Bioluminescent Imaging Mouse Model for SARS-CoV-2 Infection Based on a Pseudovirus System
by: Xi Wu, et al.
Published: (2023-06-01)

Development and optimization of a sensitive pseudovirus-based assay for HIV-1 neutralizing antibodies detection using A3R5 cells
by: Qingqing Chen, et al.
Published: (2018-01-01)

Cross-reactivity of eight SARS-CoV-2 variants rationally predicts immunogenicity clustering in sarbecoviruses
by: Qianqian Li, et al.
Published: (2022-07-01)

The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron
by: Li Zhang, et al.
Published: (2022-12-01)

Improved computational epitope profiling using structural models identifies a broader diversity of antibodies that bind to the same epitope
by: Fabian C. Spoendlin, et al.
Published: (2023-09-01)

Assessing the neutralizing antibody and duration of RNA positivity from COVID-19 infected patients with immunocompromised diseases and pneumonia
by: Shuo Liu, et al.
Published: (2024-07-01)

Epitope Profiling Reveals the Critical Antigenic Determinants in SARS-CoV-2 RBD-Based Antigen
by: Min Jiang, et al.
Published: (2021-09-01)

Tracking Immunity: An Increased Number of COVID-19 Boosters Increases the Longevity of Anti-RBD and Anti-RBD-Neutralizing Antibodies
by: Ching-Wen Hou, et al.
Published: (2025-01-01)

Multi-epitope vaccine design for hepatitis E virus based on protein ORF2 and ORF3
by: Qiong Lu, et al.
Published: (2024-03-01)

Serotype specific epitopes identified by neutralizing antibodies underpin immunogenic differences in Enterovirus B
by: Kang Wang, et al.
Published: (2020-09-01)

Hybrid Immunity from Gam-COVID-Vac Vaccination and Natural SARS-CoV-2 Infection Confers Broader Neutralizing Activity against Omicron Lineage VOCs Than Revaccination or Reinfection
by: Sergey V. Kulemzin, et al.
Published: (2024-01-01)

Rabbit Monoclonal Antibody Specifically Recognizing a Linear Epitope in the RBD of SARS-CoV-2 Spike Protein
by: Junping Hong, et al.
Published: (2021-07-01)

A bioluminescent imaging mouse model for Marburg virus based on a pseudovirus system
by: Li Zhang, et al.
Published: (2017-08-01)

Identification of Closed Linear Epitopes in S1-RBD and S2-HR1/2 of SARS-CoV-2 Spike Protein Able to Induce Neutralizing Abs
by: Yoshihiro Watanabe, et al.
Published: (2023-01-01)

Analysis of SARS-CoV-2 variants B.1.617: host tropism, proteolytic activation, cell–cell fusion, and neutralization sensitivity
by: Li Zhang, et al.
Published: (2022-12-01)

SARS-CoV-2 Neutralization Assays Used in Clinical Trials: A Narrative Review
by: Yeqing Sun, et al.
Published: (2024-05-01)

Neutralizing Potency of Prototype and Omicron RBD mRNA Vaccines Against Omicron Variant
by: Jinkai Zang, et al.
Published: (2022-06-01)

Identification of an IGHV3-53-Encoded RBD-Targeting Cross-Neutralizing Antibody from an Early COVID-19 Convalescent
by: Yuanyuan Hu, et al.
Published: (2024-03-01)

Evolutionary and spatiotemporal analyses reveal multiple introductions and cryptic transmission of SARS-CoV-2 VOC/VOI in Malta
by: Nidia S. Trovao, et al.
Published: (2023-12-01)